Soombit AI Raises $9.1M Series A
Soombit AI raises $9.1M Series A led by SV Investment to expand its generative AI medical imaging software into CT and MRI diagnostics.
Soombit AI Raises $9.1M Series A
Soombit AI, based in South Korea, a generative AI company specializing in medical imaging reading solutions, has raised $9.1 million in a Series A funding round. The startup also announced its selection for the Ministry of SMEs and Startups Scale-up TIPS program, which provides additional R&D funding support.
Investors
The round was led by SV Investment, with participation from Altos Ventures, Kiwoom Investment, and iM Investment Partners.
Soombit AI Use of Funds
Soombit AI intends to use the new capital to expand its product line beyond chest X-ray reading solutions into three-dimensional multi-sequence imaging, specifically CT and MRI. The company plans to develop AIRead-CT, a preliminary-findings solution for brain, chest, abdomen, and pelvic imaging, and pursue global regulatory approvals, including US FDA clearance and European CE marking.
About Soombit AI
Founded in July 2024 by CEO Woong Bae and a team of alumni from Kakao Brain, Soombit AI is dedicated to building generative AI solutions for radiology. Their flagship product, AIRead-CXR, is a Class 3 digital medical device approved for automatically drafting chest X-ray reading reports by analyzing images and generating preliminary clinical findings.
Funding Details
Company Website: https://soombit.ai
Company: Soombit AI
Raised: $9.1M
Round: Series A
Funding Date: November 18, 2026
Lead Investor: SV Investment
Additional Investors: Altos Ventures, Kiwoom Investment, iM Investment Partners
Company Website: https://soombit.ai
Software Category: HealthTech
Source: https://en.wowtale.net/2026/11/18/236076/